GILD Gilead Sciences, Inc.
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official
Market Value*
$103.20B
Revenue (FY)
$29.44B 2025-12-31
Net Income (FY)
$8.51B
P/E (float-based)
12.1
American biopharmaceutical company.
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official
American biopharmaceutical company.